Claudio Ortolani (Ospedale dell'Angelo, Venice, Italy)
Flow Cytometry of Hematological Malignacies
Claudio Ortolani (Ospedale dell'Angelo, Venice, Italy)
Flow Cytometry of Hematological Malignacies
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Flow Cytometry of Hematological Malignancies bietet eine Vielzahl grafisch aufbereiteter Ergebnisse, die mit der Durchflusszytometrie bei der Untersuchung der häufigsten Erkrankungen gewonnen wurden. Auch weniger bekannte Krankheiten werden vorgestellt.
Das Fachbuch wurde als Referenzwerk zum schnellen Nachschlagen konzipiert. Es ist ein Muss für Kliniker, die hämatologische Erkrankungen diagnostizieren und analysieren, darunter Hämatologen, Hämatopathologen, Onkologen, Pathologen und Mitarbeiter in diagnostischen Labors.
Andere Kunden interessierten sich auch für
- Barbara J. Bain (St Mary's Hospital, London, UK)Haemoglobinopathy Diagnosis196,99 €
- Textbook of Von Willebrand Disease125,99 €
- Caroline A. Hastings (Pediatric Hematology and Children?s OncologyHandbook of Pediatric Hematology and Oncology68,99 €
- Barbara J. Bain (Imperial College LondonHematology59,99 €
- ABC of Clinical Haematology54,99 €
- Barbara J. Bain (St Mary's Hospital, London, UK)Blood Cells167,99 €
- Sverre Heim (Norway The Norwegian Radium Hospital)Abnormal Chromosomes134,99 €
-
-
-
Flow Cytometry of Hematological Malignancies bietet eine Vielzahl grafisch aufbereiteter Ergebnisse, die mit der Durchflusszytometrie bei der Untersuchung der häufigsten Erkrankungen gewonnen wurden. Auch weniger bekannte Krankheiten werden vorgestellt.
Das Fachbuch wurde als Referenzwerk zum schnellen Nachschlagen konzipiert. Es ist ein Muss für Kliniker, die hämatologische Erkrankungen diagnostizieren und analysieren, darunter Hämatologen, Hämatopathologen, Onkologen, Pathologen und Mitarbeiter in diagnostischen Labors.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Das Fachbuch wurde als Referenzwerk zum schnellen Nachschlagen konzipiert. Es ist ein Muss für Kliniker, die hämatologische Erkrankungen diagnostizieren und analysieren, darunter Hämatologen, Hämatopathologen, Onkologen, Pathologen und Mitarbeiter in diagnostischen Labors.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Wiley & Sons / Wiley-Blackwell
- Artikelnr. des Verlages: 1W119611250
- 2. Aufl.
- Seitenzahl: 464
- Erscheinungstermin: 14. April 2021
- Englisch
- Abmessung: 280mm x 216mm x 25mm
- Gewicht: 1518g
- ISBN-13: 9781119611257
- ISBN-10: 1119611253
- Artikelnr.: 59857679
- Verlag: Wiley & Sons / Wiley-Blackwell
- Artikelnr. des Verlages: 1W119611250
- 2. Aufl.
- Seitenzahl: 464
- Erscheinungstermin: 14. April 2021
- Englisch
- Abmessung: 280mm x 216mm x 25mm
- Gewicht: 1518g
- ISBN-13: 9781119611257
- ISBN-10: 1119611253
- Artikelnr.: 59857679
About the author Claudio Ortolani is an expert in the area of diagnosis of hematological malignancies. Now retired, Dr Ortolani was Consultant in the Department of Clinical Pathology at Venice General Hospital, Venice, Italy. He is one of the founding members of the Italian Society for Cytometric Cell Analysis (ISCCA), of whose board he is currently a member. He has taught and lectured internationally on how to use flow cytometry to aid in diagnosing hematological diseases.
Foreword to the First Edition by Maryalice Stetler-Stevenson
Foreword to the First Edition by Bruno Brando
Foreword to the Second Edition by Michael J Borowitz
Preface to the First Edition
Preface to the Second Edition
1 ANTIGENS
Clustered (CD) Antigens
CD1 Antigens, XX
CD2 Antigen, XX
CD3 Antigen, XX
CD4 Antigen, XX
CD5 Antigen, XX
CD7 Antigen, XX
CD8 Antigen, XX
CD10 Antigen, XX
CD11b Antigen, XX
CD11c Antigen, XX
CD13 Antigen, XX
CD14 Antigen, XX
CD15 Antigen, XX
CD16 Antigen, XX
CD19 Antigen, XX
CD20 Antigen, XX
CD22 Antigen, XX
CD23 Antigen, XX
CD24 Antigen, XX
CD25 Antigen, XX
CD26 Antigen, XX
CD27 Antigen, XX
CD28 Antigen, XX
CD30 Antigen, XX
CD33 Antigen, XX
CD34 Antigen, XX
CD38 Antigen, XX
CD43 Antigen, XX
CD45 Antigen, XX
CD45 Isoforms, XX
CD48 Antigen, see SLAM molecules, XX
CD49 Antigens, XX
CD56 Antigen, XX
CD57 Antigen, XX
CD61 Antigen, XX
CD62L Antigen, XX
CD64 Antigen, XX
CD65 Antigen, XX
CD66c Antigen, XX
CD71 Antigen, XX
CD79 Antigen, XX
CD81 Antigen, XX
CD84 Antigen, see SLAM molecules, XX
CD103 Antigen, XX
CD123 Antigen, XX
CD117 Antigen, XX
CD138 Antigen, XX
CD150 Antigen, see SLAM molecules, XX
CD158 Antigen, see KIRs, XX
CD181-186, 191-199 Antigens, see Chemokines and Chemokine Receptors, XX
CD200 Antigen, XX
CD229 Antigen, see SLAM molecules, XX
CD244 Antigen, see SLAM molecules, XX
CD280-290 Antigens, see Toll-like Receptors, XX
CD305 Antigen, XX
CD307 (IRTA) Antigen Family, XX
CD319 Antigen, see SLAM molecules, XX
CD352-353 Antigens, see SLAM molecules, XX
CD371 Antigen, XX
Non clustered (or primarily known with other names) antigens
Bcl-2 Protein, XX
Chemokines and Chemokine Receptors, XX
CRLF2, XX
Cytotoxic Proteins, XX
HLA-DR Antigen, XX
Immunoglobulins, XX
KIR, CD158 Isoforms, XX
Myeloperoxidase (MPO), XX
NG2 Antigen, XX
PCA-1 Antigen, XX
ROR-1 Antigen, XX
SLAM Molecules and SLAM Associated Protein (SAP), XX
SOX11, XX
T-cell Receptor (TCR), XX
Terminal Deoxy-nucleotidyl Transferase (TdT), XX
Toll-like Receptors (TLR), XX
VS38 Antigen, XX
ZAP-70 Protein, XX
2 DISEASES
Myeloproliferative neoplasms, XXX
Chronic myeloid leukemia (CML), XXX
Myeloproliferative neoplasms other than CML, XXX
Chronic neutrophilic leukemia (CNL), XXX
Polycythemia vera (PV), XXX
Primary myelofibrosis (PMF), XXX
Essential thrombocythemia (ET), XXX
Chronic eosinophilic leukemia (CEL), XXX
Mastocytosis, XXX
Acute masT-cell leukemia (AMCL), XXX
Chronic masT-cell leukemia (CMCL), XXX
Myelomastocytic leukemia (MML), XXX
Myelodysplastic/myeloproliferative neoplasms, XXX
Chronic myelomonocytic leukemia (CMML), XXX
Other myelodysplastic/myeloproliferative neoplasms and related conditions, XXX
Juvenile myelomonocytic leukemia (JMML), XXX
&
Foreword to the First Edition by Bruno Brando
Foreword to the Second Edition by Michael J Borowitz
Preface to the First Edition
Preface to the Second Edition
1 ANTIGENS
Clustered (CD) Antigens
CD1 Antigens, XX
CD2 Antigen, XX
CD3 Antigen, XX
CD4 Antigen, XX
CD5 Antigen, XX
CD7 Antigen, XX
CD8 Antigen, XX
CD10 Antigen, XX
CD11b Antigen, XX
CD11c Antigen, XX
CD13 Antigen, XX
CD14 Antigen, XX
CD15 Antigen, XX
CD16 Antigen, XX
CD19 Antigen, XX
CD20 Antigen, XX
CD22 Antigen, XX
CD23 Antigen, XX
CD24 Antigen, XX
CD25 Antigen, XX
CD26 Antigen, XX
CD27 Antigen, XX
CD28 Antigen, XX
CD30 Antigen, XX
CD33 Antigen, XX
CD34 Antigen, XX
CD38 Antigen, XX
CD43 Antigen, XX
CD45 Antigen, XX
CD45 Isoforms, XX
CD48 Antigen, see SLAM molecules, XX
CD49 Antigens, XX
CD56 Antigen, XX
CD57 Antigen, XX
CD61 Antigen, XX
CD62L Antigen, XX
CD64 Antigen, XX
CD65 Antigen, XX
CD66c Antigen, XX
CD71 Antigen, XX
CD79 Antigen, XX
CD81 Antigen, XX
CD84 Antigen, see SLAM molecules, XX
CD103 Antigen, XX
CD123 Antigen, XX
CD117 Antigen, XX
CD138 Antigen, XX
CD150 Antigen, see SLAM molecules, XX
CD158 Antigen, see KIRs, XX
CD181-186, 191-199 Antigens, see Chemokines and Chemokine Receptors, XX
CD200 Antigen, XX
CD229 Antigen, see SLAM molecules, XX
CD244 Antigen, see SLAM molecules, XX
CD280-290 Antigens, see Toll-like Receptors, XX
CD305 Antigen, XX
CD307 (IRTA) Antigen Family, XX
CD319 Antigen, see SLAM molecules, XX
CD352-353 Antigens, see SLAM molecules, XX
CD371 Antigen, XX
Non clustered (or primarily known with other names) antigens
Bcl-2 Protein, XX
Chemokines and Chemokine Receptors, XX
CRLF2, XX
Cytotoxic Proteins, XX
HLA-DR Antigen, XX
Immunoglobulins, XX
KIR, CD158 Isoforms, XX
Myeloperoxidase (MPO), XX
NG2 Antigen, XX
PCA-1 Antigen, XX
ROR-1 Antigen, XX
SLAM Molecules and SLAM Associated Protein (SAP), XX
SOX11, XX
T-cell Receptor (TCR), XX
Terminal Deoxy-nucleotidyl Transferase (TdT), XX
Toll-like Receptors (TLR), XX
VS38 Antigen, XX
ZAP-70 Protein, XX
2 DISEASES
Myeloproliferative neoplasms, XXX
Chronic myeloid leukemia (CML), XXX
Myeloproliferative neoplasms other than CML, XXX
Chronic neutrophilic leukemia (CNL), XXX
Polycythemia vera (PV), XXX
Primary myelofibrosis (PMF), XXX
Essential thrombocythemia (ET), XXX
Chronic eosinophilic leukemia (CEL), XXX
Mastocytosis, XXX
Acute masT-cell leukemia (AMCL), XXX
Chronic masT-cell leukemia (CMCL), XXX
Myelomastocytic leukemia (MML), XXX
Myelodysplastic/myeloproliferative neoplasms, XXX
Chronic myelomonocytic leukemia (CMML), XXX
Other myelodysplastic/myeloproliferative neoplasms and related conditions, XXX
Juvenile myelomonocytic leukemia (JMML), XXX
&
Foreword to the First Edition by Maryalice Stetler-Stevenson
Foreword to the First Edition by Bruno Brando
Foreword to the Second Edition by Michael J Borowitz
Preface to the First Edition
Preface to the Second Edition
1 ANTIGENS
Clustered (CD) Antigens
CD1 Antigens, XX
CD2 Antigen, XX
CD3 Antigen, XX
CD4 Antigen, XX
CD5 Antigen, XX
CD7 Antigen, XX
CD8 Antigen, XX
CD10 Antigen, XX
CD11b Antigen, XX
CD11c Antigen, XX
CD13 Antigen, XX
CD14 Antigen, XX
CD15 Antigen, XX
CD16 Antigen, XX
CD19 Antigen, XX
CD20 Antigen, XX
CD22 Antigen, XX
CD23 Antigen, XX
CD24 Antigen, XX
CD25 Antigen, XX
CD26 Antigen, XX
CD27 Antigen, XX
CD28 Antigen, XX
CD30 Antigen, XX
CD33 Antigen, XX
CD34 Antigen, XX
CD38 Antigen, XX
CD43 Antigen, XX
CD45 Antigen, XX
CD45 Isoforms, XX
CD48 Antigen, see SLAM molecules, XX
CD49 Antigens, XX
CD56 Antigen, XX
CD57 Antigen, XX
CD61 Antigen, XX
CD62L Antigen, XX
CD64 Antigen, XX
CD65 Antigen, XX
CD66c Antigen, XX
CD71 Antigen, XX
CD79 Antigen, XX
CD81 Antigen, XX
CD84 Antigen, see SLAM molecules, XX
CD103 Antigen, XX
CD123 Antigen, XX
CD117 Antigen, XX
CD138 Antigen, XX
CD150 Antigen, see SLAM molecules, XX
CD158 Antigen, see KIRs, XX
CD181-186, 191-199 Antigens, see Chemokines and Chemokine Receptors, XX
CD200 Antigen, XX
CD229 Antigen, see SLAM molecules, XX
CD244 Antigen, see SLAM molecules, XX
CD280-290 Antigens, see Toll-like Receptors, XX
CD305 Antigen, XX
CD307 (IRTA) Antigen Family, XX
CD319 Antigen, see SLAM molecules, XX
CD352-353 Antigens, see SLAM molecules, XX
CD371 Antigen, XX
Non clustered (or primarily known with other names) antigens
Bcl-2 Protein, XX
Chemokines and Chemokine Receptors, XX
CRLF2, XX
Cytotoxic Proteins, XX
HLA-DR Antigen, XX
Immunoglobulins, XX
KIR, CD158 Isoforms, XX
Myeloperoxidase (MPO), XX
NG2 Antigen, XX
PCA-1 Antigen, XX
ROR-1 Antigen, XX
SLAM Molecules and SLAM Associated Protein (SAP), XX
SOX11, XX
T-cell Receptor (TCR), XX
Terminal Deoxy-nucleotidyl Transferase (TdT), XX
Toll-like Receptors (TLR), XX
VS38 Antigen, XX
ZAP-70 Protein, XX
2 DISEASES
Myeloproliferative neoplasms, XXX
Chronic myeloid leukemia (CML), XXX
Myeloproliferative neoplasms other than CML, XXX
Chronic neutrophilic leukemia (CNL), XXX
Polycythemia vera (PV), XXX
Primary myelofibrosis (PMF), XXX
Essential thrombocythemia (ET), XXX
Chronic eosinophilic leukemia (CEL), XXX
Mastocytosis, XXX
Acute masT-cell leukemia (AMCL), XXX
Chronic masT-cell leukemia (CMCL), XXX
Myelomastocytic leukemia (MML), XXX
Myelodysplastic/myeloproliferative neoplasms, XXX
Chronic myelomonocytic leukemia (CMML), XXX
Other myelodysplastic/myeloproliferative neoplasms and related conditions, XXX
Juvenile myelomonocytic leukemia (JMML), XXX
&
Foreword to the First Edition by Bruno Brando
Foreword to the Second Edition by Michael J Borowitz
Preface to the First Edition
Preface to the Second Edition
1 ANTIGENS
Clustered (CD) Antigens
CD1 Antigens, XX
CD2 Antigen, XX
CD3 Antigen, XX
CD4 Antigen, XX
CD5 Antigen, XX
CD7 Antigen, XX
CD8 Antigen, XX
CD10 Antigen, XX
CD11b Antigen, XX
CD11c Antigen, XX
CD13 Antigen, XX
CD14 Antigen, XX
CD15 Antigen, XX
CD16 Antigen, XX
CD19 Antigen, XX
CD20 Antigen, XX
CD22 Antigen, XX
CD23 Antigen, XX
CD24 Antigen, XX
CD25 Antigen, XX
CD26 Antigen, XX
CD27 Antigen, XX
CD28 Antigen, XX
CD30 Antigen, XX
CD33 Antigen, XX
CD34 Antigen, XX
CD38 Antigen, XX
CD43 Antigen, XX
CD45 Antigen, XX
CD45 Isoforms, XX
CD48 Antigen, see SLAM molecules, XX
CD49 Antigens, XX
CD56 Antigen, XX
CD57 Antigen, XX
CD61 Antigen, XX
CD62L Antigen, XX
CD64 Antigen, XX
CD65 Antigen, XX
CD66c Antigen, XX
CD71 Antigen, XX
CD79 Antigen, XX
CD81 Antigen, XX
CD84 Antigen, see SLAM molecules, XX
CD103 Antigen, XX
CD123 Antigen, XX
CD117 Antigen, XX
CD138 Antigen, XX
CD150 Antigen, see SLAM molecules, XX
CD158 Antigen, see KIRs, XX
CD181-186, 191-199 Antigens, see Chemokines and Chemokine Receptors, XX
CD200 Antigen, XX
CD229 Antigen, see SLAM molecules, XX
CD244 Antigen, see SLAM molecules, XX
CD280-290 Antigens, see Toll-like Receptors, XX
CD305 Antigen, XX
CD307 (IRTA) Antigen Family, XX
CD319 Antigen, see SLAM molecules, XX
CD352-353 Antigens, see SLAM molecules, XX
CD371 Antigen, XX
Non clustered (or primarily known with other names) antigens
Bcl-2 Protein, XX
Chemokines and Chemokine Receptors, XX
CRLF2, XX
Cytotoxic Proteins, XX
HLA-DR Antigen, XX
Immunoglobulins, XX
KIR, CD158 Isoforms, XX
Myeloperoxidase (MPO), XX
NG2 Antigen, XX
PCA-1 Antigen, XX
ROR-1 Antigen, XX
SLAM Molecules and SLAM Associated Protein (SAP), XX
SOX11, XX
T-cell Receptor (TCR), XX
Terminal Deoxy-nucleotidyl Transferase (TdT), XX
Toll-like Receptors (TLR), XX
VS38 Antigen, XX
ZAP-70 Protein, XX
2 DISEASES
Myeloproliferative neoplasms, XXX
Chronic myeloid leukemia (CML), XXX
Myeloproliferative neoplasms other than CML, XXX
Chronic neutrophilic leukemia (CNL), XXX
Polycythemia vera (PV), XXX
Primary myelofibrosis (PMF), XXX
Essential thrombocythemia (ET), XXX
Chronic eosinophilic leukemia (CEL), XXX
Mastocytosis, XXX
Acute masT-cell leukemia (AMCL), XXX
Chronic masT-cell leukemia (CMCL), XXX
Myelomastocytic leukemia (MML), XXX
Myelodysplastic/myeloproliferative neoplasms, XXX
Chronic myelomonocytic leukemia (CMML), XXX
Other myelodysplastic/myeloproliferative neoplasms and related conditions, XXX
Juvenile myelomonocytic leukemia (JMML), XXX
&